| Detection of a SARS-CoV-2 variant of concern in South Africa H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ... Nature 592 (7854), 438-443, 2021 | 2679* | 2021 |
| Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa R Viana, S Moyo, DG Amoako, H Tegally, C Scheepers, CL Althaus, ... Nature 603 (7902), 679-686, 2022 | 1405 | 2022 |
| Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ... New England Journal of Medicine 384 (20), 1885-1898, 2021 | 1369 | 2021 |
| SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ... Nature medicine 27 (4), 622-625, 2021 | 1265 | 2021 |
| Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study N Wolter, W Jassat, S Walaza, R Welch, H Moultrie, M Groome, ... The Lancet 399 (10323), 437-446, 2022 | 1026 | 2022 |
| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 1005 | 2022 |
| Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies NA Doria-Rose, CA Schramm, J Gorman, PL Moore, JN Bhiman, ... Nature 509 (7498), 55-62, 2014 | 779 | 2014 |
| Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a … Y Li, X Wang, DM Blau, MT Caballero, DR Feikin, CJ Gill, SA Madhi, ... The Lancet 399 (10340), 2047-2064, 2022 | 585 | 2022 |
| Emergence of SARS-CoV-2 omicron lineages BA. 4 and BA. 5 in South Africa H Tegally, M Moir, J Everatt, M Giovanetti, C Scheepers, E Wilkinson, ... Nature medicine 28 (9), 1785-1790, 2022 | 514 | 2022 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 485 | 2022 |
| Sixteen novel lineages of SARS-CoV-2 in South Africa H Tegally, E Wilkinson, RJ Lessells, J Giandhari, S Pillay, N Msomi, ... Nature medicine 27 (3), 440-446, 2021 | 387 | 2021 |
| Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape PL Moore, ES Gray, CK Wibmer, JN Bhiman, M Nonyane, DJ Sheward, ... Nature medicine 18 (11), 1688-1692, 2012 | 374 | 2012 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... MedRxiv, 2021 | 362 | 2021 |
| SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse F Konings, MD Perkins, JH Kuhn, MJ Pallen, EJ Alm, BN Archer, ... Nature microbiology 6 (7), 821-823, 2021 | 246 | 2021 |
| New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency NA Doria-Rose, JN Bhiman, RS Roark, CA Schramm, J Gorman, ... Journal of virology 90 (1), 76-91, 2016 | 241 | 2016 |
| Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies JN Bhiman, C Anthony, NA Doria-Rose, O Karimanzira, CA Schramm, ... Nature medicine 21 (11), 1332-1336, 2015 | 224 | 2015 |
| Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes CK Wibmer, JN Bhiman, ES Gray, N Tumba, SS Abdool Karim, ... PLoS pathogens 9 (10), e1003738, 2013 | 224 | 2013 |
| SARS-CoV-2 501Y CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ... V2 escapes neutralization by South African COVID-19 donor plasma. bioRxiv …, 2021 | 201 | 2021 |
| Engineered immunogen binding to alum adjuvant enhances humoral immunity TJ Moyer, Y Kato, W Abraham, JYH Chang, DW Kulp, N Watson, ... Nature Medicine 26 (3), 430-440, 2020 | 197 | 2020 |
| Engineered immunogen binding to alum adjuvant enhances humoral immunity TJ Moyer, Y Kato, W Abraham, JYH Chang, DW Kulp, N Watson, ... Nature Medicine 26 (3), 430-440, 2020 | 195 | 2020 |
Constantinos Kurt WibmerNational Institute for Communicable DiseasesDirección de correo verificada de nicd.ac.za
